Interstistial Lung Disease
Lung cancer is a condition that causes cells to divide in the lungs uncontrollably. This causes the growth of tumors that reduce a person's ability to breathe. In lung cancer, this pattern of cell overgrowth occurs in the lungs, which are vital organs for breathing and gas exchange. Cigarette smoking is the principal risk factor for development of lung cancer, Passive exposure to tobacco smoke (passive smoking) also can cause lung cancer in non-smokers. The two types of lung cancer, which grow and spread differently, are small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC). Medical professionals also refer to them as small-cell lung carcinoma and non q-small-cell lung carcinoma.
The stage of lung cancer refers to the extent to which the cancer has spread in the body. Treatment of lung cancer can involve a combination of surgery, chemotherapy, targeted therapy, immunotherapy, and radiation therapy as well as newer experimental methods. The general prognosis of lung cancer is poor because doctors tend not to find the disease until it is at an advanced stage. Five-year survival is around 54% for early stage lung cancer patients that have a tumor localized to the lungs, but only around 4% in those with advanced, inoperable lung cancer. Smoking cessation is the most important measure that can prevent the development of lung cancer.
- What are the causes of interstitial lung disease?
- Diagnosis for Interstitial lung disease
- Risk factors for interstitial lung disease
Related Conference of Interstistial Lung Disease
14th International Conference on COPD Clinical Trials & Lung Care Advances
6th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
16th International Conference on Pulmonary & Respiratory Medicine
18th International Conference on Chronic Obstructive Pulmonary Disease
Interstistial Lung Disease Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- AI in Respiratory Care - COPD SUMMIT 2026 (Italy)
- Air Pollution & Tobacco Control - COPD SUMMIT 2026 (Italy)
- Asthma COPD Overlap (ACO) - COPD SUMMIT 2026 (Italy)
- Asthma: New Insights & Therapies - COPD SUMMIT 2026 (Italy)
- Bronchoscopy & Airway Techniques - COPD SUMMIT 2026 (Italy)
- Cardiopulmonary Disease - Tuberculosis-2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2026 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2026 (France)
- COPD & Cardiovascular Diseases - COPD SUMMIT 2026 (Italy)
- COPD Diagnosis & Guidelines - COPD SUMMIT 2026 (Italy)
- COPD Innovations - PULMONOLOGY 2026 (France)
- COPD Pathogenesis - COPD SUMMIT 2026 (Italy)
- COPD Pharmacotherapy - COPD SUMMIT 2026 (Italy)
- COPD Prevention & Self-Management - COPD SUMMIT 2026 (Italy)
- COPD: Advances & Management - COPD SUMMIT 2026 (Italy)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Cystic Fibrosis - COPD SUMMIT 2026 (Italy)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Drug-Resistant Tuberculosis: - Tuberculosis-2026 (France)
- Early Detection and Diagnosis - Tuberculosis-2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Epidemiology of TB Disease - Tuberculosis-2026 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2026 (France)
- Infection Control Measures - Tuberculosis-2026 (France)
- Integrated Healthcare Approach - Tuberculosis-2026 (France)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - COPD SUMMIT 2026 (Italy)
- Latent TB Infection and Active TB Disease - Tuberculosis-2026 (France)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Lung Cancer: Diagnosis & Treatment - COPD SUMMIT 2026 (Italy)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2026 (France)
- Lung Fibrosis - COPD SUMMIT 2026 (Italy)
- Lung Function in Men with and without HIV - Tuberculosis-2026 (France)
- Lung Infection - Tuberculosis-2026 (France)
- Lung Transplantation - COPD SUMMIT 2026 (Italy)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Multidrug-resistant TB - Tuberculosis-2026 (France)
- Mycobacterial Infections - Tuberculosis-2026 (France)
- Next-Gen COPD Treatments - COPD SUMMIT 2026 (Italy)
- Non-Invasive Ventilation (NIV) - COPD SUMMIT 2026 (Italy)
- Nutrition and Tuberculosis - Tuberculosis-2026 (France)
- One Health Approach to TB Control - Tuberculosis-2026 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2026 (France)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pediatric Respiratory Care - COPD SUMMIT 2026 (Italy)
- Pediatric Tuberculosis - Tuberculosis-2026 (France)
- Personalized Pulmonary Medicine - COPD SUMMIT 2026 (Italy)
- Pneumonia & Tuberculosis - COPD SUMMIT 2026 (Italy)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Preventive Therapy - Tuberculosis-2026 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2026 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2026 (France)
- Pulmonary Edema - Tuberculosis-2026 (France)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation - COPD SUMMIT 2026 (Italy)
- Research and Innovation - Tuberculosis-2026 (France)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - COPD SUMMIT 2026 (Italy)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Sleep Apnea - COPD SUMMIT 2026 (Italy)
- TB Clinical Trials - Tuberculosis-2026 (France)
- TB Vaccines - Tuberculosis-2026 (France)
- TB-HIV Co-Infection: - Tuberculosis-2026 (France)
- TB-HIV Co-infections - Tuberculosis-2026 (France)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
- Tuberculosis in Vulnerable Populations - Tuberculosis-2026 (France)
- Vaccination Programs: - Tuberculosis-2026 (France)
